-
1 Comment
Lepu Medical Technology (Beijing) Co., Ltd is currently in a long term downtrend where the price is trading 0.8% below its 200 day moving average.
From a valuation standpoint, the stock is 34.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
Lepu Medical Technology (Beijing) Co., Ltd's total revenue rose by 12.2% to $2B since the same quarter in the previous year.
Its net income has increased by 636.1% to $833M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.0% to $466M since the same quarter in the previous year.
Based on the above factors, Lepu Medical Technology (Beijing) Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100000H44 |
| Industry | Medical Devices |
| PE Ratio | 31.89 |
|---|---|
| Target Price | 20.106 |
| Dividend Yield | 2.3% |
| Market Cap | 26B |
| Beta | 0.38 |
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro diagnostics, surgical instruments, peripheral blood vessels, blood purification, ultrasound imaging, and orthopedic products; pharmaceutical products for cardiovascular, digestive, central nervous, and respiratory systems, as well as antimicrobial, nutrition, traditional Chinese medicine, lowering blood sugar, and health food; and medical services and health management, such as medical services, AI, home appliances, and medical aesthetics and daily chemical products. The company is also involved in investment activities; trading; technological development; and pension services. It exports its products. The company was founded in 1999 and is based in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300003.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
